Adding nivolumab to perioperative chemo shows no significant benefit in muscle invasive bladder cancer

ESMO 2026: Advances in NMIBC and MIBC

AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

UEG 2026: Improving early detection of colorectal cancer

Designing around lives: A decentralised, people-centred oncology care architecture from India

Using artificial intelligence to improve lung cancer screening and risk prediction

Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC

Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors

Challenges in doing clinical research in the LATAM region

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas